1. 66PAdapting a prescreening program to match molecular alterations in over 5, 000 patients' tumors with targeted agents and immunotherapies in early clinical trials over the last 8 years. (16th September 2018) Authors: Aguilar, S; Vivancos, A; Nuciforo, P; Viaplana, C; Ruiz-Pace, F; Sanchez, E; Rodon, J; Tabernero, J; Garralda, E; Dienstmann, R Journal: Annals of oncology Issue: Volume 29:Number 6(2018)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 988PBenefit from subsequent conventional cytotoxic chemotherapy (CTx) to immunotherapy (IT) in patients (pts) with gynaecological malignancies (GM). (23rd October 2018) Authors: Ros Montañá, F J; Rodriguez Freixinos, V; Fariñas Madrid, L; Amair Pinedo, F; Ruiz-Pace, F; Garralda, E; Dienstmann, R; Oaknin, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗